Effects of pay-for-performance system on tuberculosis default cases control and treatment in Taiwan.
OBJECTIVE
In order to make tuberculosis (TB) treatment more effective and to lower the default rate of the disease, the Bureau of National Health Insurance (BNHI) in Taiwan implemented the "pay-for-performance on Tuberculosis" program (P4P on TB) in 2004. The purpose of this study is to investigate the effectiveness of the P4P system in terms of default rate.


METHODS
This is a retrospective study. National Health Insurance Research Datasets in Taiwan from 2002 to 2005 has been used for the study. The study compared the differences of TB default rate before and after the implementation of P4P program, between participating and non-participating hospitals, and between P4P hospitals with and without case managers. Furthermore, logistic regression analysis was conducted to explore the related factors influencing TB patients default treatment after TB detected.


RESULTS
The treatment default rate after "P4P on TB" was 11.37% compared with the 15.56% before "P4P on TB" implementation. The treatment default rate in P4P hospitals was 10.67% compared to 12.7% in non-P4P hospitals. In addition, the default rate was 10.4% in hospitals with case managers compared with 12.68% in hospitals without case managers.


CONCLUSIONS
The results of the study showed that "P4P on TB" program improved the treatment default rate for TB patients. In addition, case managers improved the treatment outcome in controlling patients' default rate.
Tsai
Wen-Chen
WC
Department of Health Service Administration, China Medical University, Taichung, Taiwan, ROC.
Kung
Pei-Tseng
PT
Khan
Mahmud
M
Campbell
Claudia
C
Yang
Wen-Ta
WT
Lee
Tsuey-Fong
TF
Li
Ya-Hsin
YH
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009313:National Health Programs; D010349:Patient Compliance; D012052:Reimbursement, Incentive; D012189:Retrospective Studies; D013624:Taiwan; D014376:Tuberculosis / Q000188:drug therapy* / Q000191:economics*